MicroRNA-31 inhibits osteosarcoma cell proliferation, migration and invasion by targeting PIK3C2A

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Osteosarcoma is a primary bone malignancy with significant metastatic potential.
• MicroRNAs play crucial roles in cancer development and progression.
• The specific role of microRNA-31 (miR-31) in osteosarcoma remains to be fully elucidated.

Purpose of the Study:

• To investigate the expression and function of miR-31 in osteosarcoma.
• To determine the molecular mechanism underlying miR-31's effects on osteosarcoma cell behavior.
• To evaluate miR-31 as a potential therapeutic target for osteosarcoma.

Main Methods:

• Real-time quantitative polymerase chain reaction (RT-qPCR) to assess miR-31 expression in osteosarcoma tissues.
• Cell Counting Kit-8 (CCK-8) and transwell assays to evaluate cell proliferation, migration, and invasion.
• Western blot analysis to detect PIK3C2A protein levels.
• Luciferase reporter assays to confirm the direct targeting of PIK3C2A by miR-31.

Main Results:

• miR-31 was significantly downregulated in osteosarcoma tissues compared to adjacent normal tissues.
• Lower miR-31 levels correlated with high-grade tumors, metastasis, and poorer patient survival.
• Overexpression of miR-31 suppressed osteosarcoma cell proliferation, migration, and invasion in vitro.
• miR-31 directly targets and inhibits PIK3C2A, a key regulator of cell signaling.

Conclusions:

• miR-31 functions as a tumor suppressor in osteosarcoma by inhibiting cell proliferation, migration, and invasion.
• The mechanism involves the direct targeting of PIK3C2A by miR-31.
• miR-31 holds promise as a novel therapeutic target for osteosarcoma treatment.